Cancer Fund Open for Business

November 1, 2001( - AMIDEX Fund's Cancer Innovations & Healthcare Mutual Fund, the first index-based mutual fund focused on cancer cure companies, is open for business.

The new fund invests in the 45 pharmaceutical, biotechnology and medical device companies that comprise the AMIDEX eMed Cancer Innovations & Healthcare Index.

The fund includes:

  • pharmaceutical giants Merck, with 4.8 % of the portfolio, Pfizer, 8.6 % and Abbott with 2.7 %,
  • biotech leaders Chiron, accounting for 3.4% of the fund and Genentech with 9.4%, and
  • medical equipment companies Beckman Coulter, with 1% of portfolio and Cytyc 1%